Search filters

List of works by Evan Doran

An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?

scientific article published on 24 November 2011

Attitudes of physicians and public to pharmaceutical industry 'gifts'.

scientific article published on 23 March 2010

Australia's pharmaceutical cost sharing policy: reducing waste or affordability?

scientific article published on 01 May 2009

Dilemmas in the compassionate supply of investigational cancer drugs

scientific article published on 01 September 2014

Disease mongering is now part of the global health debate

scientific article (publication date: 27 May 2008)

Disease mongering: expanding the boundaries of treatable disease.

scientific article

Empirical uncertainty and moral contest: a qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia.

scientific article published on 6 September 2005

Managing ethical issues in patient care and the need for clinical ethics support

scientific article published on 17 December 2014

Mixed method integrative review exploring nurses' recognition and response to unsafe practice

scientific article

Moral hazard and prescription medicine use in Australia--the patient perspective.

scientific article published in April 2005

Part of the fabric and mostly right: an ethnography of ethics in clinical practice

scientific article published on June 2015

Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability

scientific article published on 01 February 2011

Pharmaceutical benefits scheme policy: confused and tough on patients

scientific article published on 01 April 2006

Prescription medicines: decision-making preferences of patients who receive different levels of public subsidy.

scientific article published on 12 August 2011

The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?

scientific article published on February 2013

Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry.

scientific article

Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warnin

scientific article